Kuros Biosciences AG
OTC: CSBTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Christopher T. Fair
- Employees
- 122
- Headquarters
- Schlieren, Switzerland
- IPO year
- 2014
- Market cap
- $1.0B
- Website
- https://www.kuros.ch
Loading CSBTF…
Loading profile data…Frequently asked questions about CSBTF
What does Kuros Biosciences AG (CSBTF) do?
Kuros Biosciences AG, a biopharmaceutical firm headquartered in Schlieren, Switzerland, specializes in both bringing to market and advancing therapeutic solutions for tissue repair and bone regeneration. Its global reach extends across the United States, the European Union, and other international markets, with operations strategically divided i...
Where does CSBTF trade?
Kuros Biosciences AG (CSBTF) trades on the Other OTC.
What sector is CSBTF in?
Kuros Biosciences AG (CSBTF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Kuros Biosciences AG?
Christopher T. Fair is the chief executive officer of Kuros Biosciences AG (CSBTF).
Where is Kuros Biosciences AG headquartered?
Kuros Biosciences AG is headquartered in Switzerland.
Does CSBTF pay a dividend?
Kuros Biosciences AG (CSBTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CSBTF go public?
Kuros Biosciences AG (CSBTF) completed its initial public offering in 2014.